fetching data ...

AB0182 (2020)
EVALUATION OF THE SOCIO-PROFESSIONAL IMPACT OF ANKYLOSING SPONDYLITIS AND RHEUMATOID ARTHRITIS IN TUNISIA: DATA FROM THE BINAR REGISTRY
H. Hachfi1, N. Ben Chekaya1, D. Khalifa1, M. Brahem1, H. Themri1, L. Abdelmoula2, S. Baklouti3, N. Bergaoui4, E. Bouajina5, M. Elleuch6, I. Gharssallah7, M. M. Kchir8, S. Kochbati9, A. Laatar10, Y. Mohamed11
1Taher Sfar Hospital, Mahdia, Tunisia
2Charles Nicolle Hospital, Tunis, Tunisia
3Hedi Chaker Hospital, Sfax, Tunisia
4Fattouma Bourguiba Hospital, Monastir, Tunisia
5Farhat Hached Hospital, Sousse, Tunisia
6Hospital Rabta, Tunis, Tunisia
7Military Hospital of Instruction of Tunis, Tunis, Tunisia
8Kassab Institute, Rheumatology, Tunis, Tunisia
9Habib Thameur Hospital, Tunis, Tunisia
10Mongi Slim Hospital, Tunis, Tunisia
11Taher Sfar Hospital, Mahdia, Tunisia

Background: Rheumatoid arthritis (RA) and ankylosing spondylitis (AS) are disabling and common chronic inflammatory rheumatic diseases.


Objectives: The aim of our study was to evaluate the socio-professional impact of RA and AS.


Methods: Using the Biological National Registry (BINAR) data, which includes ten tunisian rheumatology centers,we identified patients≥18 years with AS and RA according to the ACR and EULAR 2010 criteria(RA) and ASAS 2009 (AS), receiving biotherapy for less than two years.


Results: 298 patients were included in the study. The percentage of patients with RA was 58.7 % and those with AS 41.3%. The sex ratio was 0.6. The average age of the onset of the disease was 49.1 years ± 14.1 years [18–79]. For marital status, 72% were married, single (25%), widowed (2.6%) and divorced (0.4%). 22.4% of patients were illiterate, 32.7 % (primary), 28.3% (secondary) and 16.6% had an university level. For the RA population, a high disease activity (DAS28-ESR >5.1) was detected in 36% of patients, an erosive arthritis in 73.1% and 7.2% had a coxitis. In the AS group, an elevate BASDAI (BASDAI≥4) was detected in 56.9% of patients and 39% had coxitis. All patients have received Biological therapy concomitant with corticosteroids (59.1%), methotrexate (42.6%), salazopirine (20.8%) and leflunomide (4.7%). 54% of patients had a comorbidity, of which 1.7% was depression. More than half of our patients (54.3%) were unemployed, 40 % were professionally active, and 5.7% were retired due to the rheumatic condition. Absence from work was observed in 15.1% of cases with a total duration exceeding three months in 55.5% of cases. 37.9 % of patients were physically active: regularly (9.8%), irregularly (28.1%) and (62.1%) were sedentary. For the functional impact, HAQ score was 1.31± 0.7 for RA and BASFI was 5.2 ± 4.8 for AS. The working abandonment is significantly associated to: marital status (p=0.039), low level of education (p=0.04),depression (p<0.001), high activity of AS (p=0.004) and BASFI>4 (p=0,001).


Conclusion: RA or AS requiring biotherapy have a high socio-economic impact and are responsible for absenteeism at work and even for early working abandonment. Early therapeutic management and a global assessment are essential in order to improve quality of life and working conditions. Longitudinal studies are needed to assess the effect of biological therapy on the socio-professional impact of these chronic inflammatory rheumatic disease.


Disclosure of Interests: None declared


Citation: Ann Rheum Dis, volume 79, supplement 1, year 2020, page 1386
Session: Rheumatoid arthritis - prognosis, predictors and outcome (Abstracts Accepted for Publication)